In this study, all of the newly diagnosed patients with T1DM received the treatment of insulin during the period of hospitalization, only 27.4% of them adopted insulin pump therapy (CSII), and the rate had plummeted to 5.5% during the post-hospitalization sequential treatment. The gene discussed is INS; the disease is type 1 diabetes mellitus.